Cambridge Wilkinson closed a $50 million senior secured revolving credit facility for a specialty finance platform focused on litigation-related receivables.

The facility provides committed, multi-year capital to support the acquisition and financing of U.S.-based pre-settlement and medical receivables associated with personal injury claims. The transaction was structured through a bankruptcy-remote special purpose entity, with servicing retained by the originator, and includes the ability to potentially increase total commitments as the platform continues to scale.

This transaction reflects the continued use of structured private credit solutions as a scalable source of non-dilutive capital for specialty finance platforms seeking to expand asset originations while maintaining disciplined underwriting and operational control. As is often the case, this facility is designed to accordion as the company continues to originate and grow. Transaction terms were privately negotiated.

"We continue to see very strong demand from our specialty finance investors in order to help companies scale platforms, particularly with credit facilities and forward-flow programs," said Rob Bolandian, Co-Founder and Global Head of Investment Banking at Cambridge Wilkinson. "We remain focused on facilitating durable partnerships that support long-term growth for our specialty finance clients."